CHARLES TOWN, W.Va., Sept. 24 /PRNewswire-FirstCall/ -- ReBuilder Medical Technologies, Inc. (Pink Sheets: RBRM) a provider of novel electronic treatments for the pain resulting from peripheral neuropathy and arthritis today announced that the name of is newly contracted New York distributor is Med Tech Distributors LLC.
(Logo: http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGO)
Doctors can now provide the ReBuilder Treatments to their neuropathy patients in their offices on a series basis to monitor their progress and adapt the therapy to the patient's individual needs. After the series of in office treatments, these neuropathy patients can take the ReBuilder instrument home with them so they can use it 2 times per day.
"Podiatrists and chiropractors are reporting a 94% efficacy rate for their neuropathy patients," said David Phillips, Ph.D., CEO, "and patients who want a ReBuilder can now use their Medicare benefits to pay for it. This means that with their secondary insurance, peripheral neuropathy patients will have little or no money to pay out of pocket. This may result in an immediate 4 fold increase in sales for us."
Additionally, Dr. Phillips reports: "We are going to New York in October to teach our new distributor's sales staff the physiological basis for the ReBuilder when used to treat those with pain from neuropathy."
Inquiries can be made at http://www.rebuildermedical.com/.
Safe Harbor: This letter contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainty, including without limitation, the ability of the Company to successfully implement its turnaround strategy, changes in costs of raw materials, labor, and employee benefits, as well as general market conditions, competition and pricing. Although the Company believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this letter will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as representation by the Company or any other person that the objectives and plans of the Company will be achieved. In assessing forward-looking statements included herein, readers are urged to carefully read those statements. When used in the Annual Report on Form 10-K, the words "estimate," "anticipate," "expect," "believe," and similar expressions are intended to be forward-looking statements.
AP Archive: http://photoarchive.ap.org/
PRN Photo Desk, photodesk@prnewswire.com
ReBuilder Medical Technologies, Inc.
CONTACT: David B. Phillips, CEO of ReBuilder Medical Technologies, Inc.,
+1-540-454-2664, davidphillipsmail@yahoo.com
Web Site: http://www.rebuildermedical.com/
